;

Home >> Life Sciences >>

Global Cancer Biomarkers Market Report 2020 by Key Players Types Applications Countries Market Size Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

Published: Sep-2020 | Format: PDF | Maia Research | Number of pages: 105 | Code: MRS - 773563

The Cancer Biomarkers market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Cancer Biomarkers market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Cancer Biomarkers market. The report focuses on well-known providers in the global Cancer Biomarkers industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Cancer Biomarkers Industry will develop is also analyzed in detail in Chapter 1.7 of the report.
In Chapter 2.4, we analyzed industry trends in the context of COVID-19.
In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.
In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.
In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Cancer Biomarkers market covered in Chapter 4:
QIAGEN
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc
Exact Sciences Corporation
Sysmex Corporation
Quest Diagnostics
Agilent Technologies
Hologic
Abbott Laboratories
F.Hoffmann-La Roche Ltd
Roche Diagnostics
Bristol-Myers Squibb Company
Becton, Dickinson and Company
Biomérieux SA
Merck KGaA
Illumina

In Chapter 11 and 13.3, on the basis of types, the Cancer Biomarkers market from 2015 to 2026 is primarily split into:
Genetic Biomarkers
Protein Biomarkers
Glyco-biomarkers

In Chapter 12 and 13.4, on the basis of applications, the Cancer Biomarkers market from 2015 to 2026 covers:
Diagnostics
Drug Discovery and Development
Prognostics
Risk Assessment
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2026
Table of Content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Cancer Biomarkers Market Share by Type (2020-2026)
1.5.2 Genetic Biomarkers
1.5.3 Protein Biomarkers
1.5.4 Glyco-biomarkers
1.6 Market by Application
1.6.1 Global Cancer Biomarkers Market Share by Application (2020-2026)
1.6.2 Diagnostics
1.6.3 Drug Discovery and Development
1.6.4 Prognostics
1.6.5 Risk Assessment
1.6.6 Others
1.7 Cancer Biomarkers Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Cancer Biomarkers Industry Development

2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19

3 Value Chain of Cancer Biomarkers Market
3.1 Value Chain Status
3.2 Cancer Biomarkers Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Cancer Biomarkers
3.2.3 Labor Cost of Cancer Biomarkers
3.2.3.1 Labor Cost of Cancer Biomarkers Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19

4 Players Profiles
4.1 QIAGEN
4.1.1 QIAGEN Basic Information
4.1.2 Cancer Biomarkers Product Profiles, Application and Specification
4.1.3 QIAGEN Cancer Biomarkers Market Performance (2015-2020)
4.1.4 QIAGEN Business Overview
4.2 Thermo Fisher Scientific, Inc.
4.2.1 Thermo Fisher Scientific, Inc. Basic Information
4.2.2 Cancer Biomarkers Product Profiles, Application and Specification
4.2.3 Thermo Fisher Scientific, Inc. Cancer Biomarkers Market Performance (2015-2020)
4.2.4 Thermo Fisher Scientific, Inc. Business Overview
4.3 Bio-Rad Laboratories, Inc
4.3.1 Bio-Rad Laboratories, Inc Basic Information
4.3.2 Cancer Biomarkers Product Profiles, Application and Specification
4.3.3 Bio-Rad Laboratories, Inc Cancer Biomarkers Market Performance (2015-2020)
4.3.4 Bio-Rad Laboratories, Inc Business Overview
4.4 Exact Sciences Corporation
4.4.1 Exact Sciences Corporation Basic Information
4.4.2 Cancer Biomarkers Product Profiles, Application and Specification
4.4.3 Exact Sciences Corporation Cancer Biomarkers Market Performance (2015-2020)
4.4.4 Exact Sciences Corporation Business Overview
4.5 Sysmex Corporation
4.5.1 Sysmex Corporation Basic Information
4.5.2 Cancer Biomarkers Product Profiles, Application and Specification
4.5.3 Sysmex Corporation Cancer Biomarkers Market Performance (2015-2020)
4.5.4 Sysmex Corporation Business Overview
4.6 Quest Diagnostics
4.6.1 Quest Diagnostics Basic Information
4.6.2 Cancer Biomarkers Product Profiles, Application and Specification
4.6.3 Quest Diagnostics Cancer Biomarkers Market Performance (2015-2020)
4.6.4 Quest Diagnostics Business Overview
4.7 Agilent Technologies
4.7.1 Agilent Technologies Basic Information
4.7.2 Cancer Biomarkers Product Profiles, Application and Specification
4.7.3 Agilent Technologies Cancer Biomarkers Market Performance (2015-2020)
4.7.4 Agilent Technologies Business Overview
4.8 Hologic
4.8.1 Hologic Basic Information
4.8.2 Cancer Biomarkers Product Profiles, Application and Specification
4.8.3 Hologic Cancer Biomarkers Market Performance (2015-2020)
4.8.4 Hologic Business Overview
4.9 Abbott Laboratories
4.9.1 Abbott Laboratories Basic Information
4.9.2 Cancer Biomarkers Product Profiles, Application and Specification
4.9.3 Abbott Laboratories Cancer Biomarkers Market Performance (2015-2020)
4.9.4 Abbott Laboratories Business Overview
4.10 F.Hoffmann-La Roche Ltd
4.10.1 F.Hoffmann-La Roche Ltd Basic Information
4.10.2 Cancer Biomarkers Product Profiles, Application and Specification
4.10.3 F.Hoffmann-La Roche Ltd Cancer Biomarkers Market Performance (2015-2020)
4.10.4 F.Hoffmann-La Roche Ltd Business Overview
4.11 Roche Diagnostics
4.11.1 Roche Diagnostics Basic Information
4.11.2 Cancer Biomarkers Product Profiles, Application and Specification
4.11.3 Roche Diagnostics Cancer Biomarkers Market Performance (2015-2020)
4.11.4 Roche Diagnostics Business Overview
4.12 Bristol-Myers Squibb Company
4.12.1 Bristol-Myers Squibb Company Basic Information
4.12.2 Cancer Biomarkers Product Profiles, Application and Specification
4.12.3 Bristol-Myers Squibb Company Cancer Biomarkers Market Performance (2015-2020)
4.12.4 Bristol-Myers Squibb Company Business Overview
4.13 Becton, Dickinson and Company
4.13.1 Becton, Dickinson and Company Basic Information
4.13.2 Cancer Biomarkers Product Profiles, Application and Specification
4.13.3 Becton, Dickinson and Company Cancer Biomarkers Market Performance (2015-2020)
4.13.4 Becton, Dickinson and Company Business Overview
4.14 Biomérieux SA
4.14.1 Biomérieux SA Basic Information
4.14.2 Cancer Biomarkers Product Profiles, Application and Specification
4.14.3 Biomérieux SA Cancer Biomarkers Market Performance (2015-2020)
4.14.4 Biomérieux SA Business Overview
4.15 Merck KGaA
4.15.1 Merck KGaA Basic Information
4.15.2 Cancer Biomarkers Product Profiles, Application and Specification
4.15.3 Merck KGaA Cancer Biomarkers Market Performance (2015-2020)
4.15.4 Merck KGaA Business Overview
4.16 Illumina
4.16.1 Illumina Basic Information
4.16.2 Cancer Biomarkers Product Profiles, Application and Specification
4.16.3 Illumina Cancer Biomarkers Market Performance (2015-2020)
4.16.4 Illumina Business Overview

5 Global Cancer Biomarkers Market Analysis by Regions
5.1 Global Cancer Biomarkers Sales, Revenue and Market Share by Regions
5.1.1 Global Cancer Biomarkers Sales by Regions (2015-2020)
5.1.2 Global Cancer Biomarkers Revenue by Regions (2015-2020)
5.2 North America Cancer Biomarkers Sales and Growth Rate (2015-2020)
5.3 Europe Cancer Biomarkers Sales and Growth Rate (2015-2020)
5.4 Asia-Pacific Cancer Biomarkers Sales and Growth Rate (2015-2020)
5.5 Middle East and Africa Cancer Biomarkers Sales and Growth Rate (2015-2020)
5.6 South America Cancer Biomarkers Sales and Growth Rate (2015-2020)

6 North America Cancer Biomarkers Market Analysis by Countries
6.1 North America Cancer Biomarkers Sales, Revenue and Market Share by Countries
6.1.1 North America Cancer Biomarkers Sales by Countries (2015-2020)
6.1.2 North America Cancer Biomarkers Revenue by Countries (2015-2020)
6.1.3 North America Cancer Biomarkers Market Under COVID-19
6.2 United States Cancer Biomarkers Sales and Growth Rate (2015-2020)
6.2.1 United States Cancer Biomarkers Market Under COVID-19
6.3 Canada Cancer Biomarkers Sales and Growth Rate (2015-2020)
6.4 Mexico Cancer Biomarkers Sales and Growth Rate (2015-2020)

7 Europe Cancer Biomarkers Market Analysis by Countries
7.1 Europe Cancer Biomarkers Sales, Revenue and Market Share by Countries
7.1.1 Europe Cancer Biomarkers Sales by Countries (2015-2020)
7.1.2 Europe Cancer Biomarkers Revenue by Countries (2015-2020)
7.1.3 Europe Cancer Biomarkers Market Under COVID-19
7.2 Germany Cancer Biomarkers Sales and Growth Rate (2015-2020)
7.2.1 Germany Cancer Biomarkers Market Under COVID-19
7.3 UK Cancer Biomarkers Sales and Growth Rate (2015-2020)
7.3.1 UK Cancer Biomarkers Market Under COVID-19
7.4 France Cancer Biomarkers Sales and Growth Rate (2015-2020)
7.4.1 France Cancer Biomarkers Market Under COVID-19
7.5 Italy Cancer Biomarkers Sales and Growth Rate (2015-2020)
7.5.1 Italy Cancer Biomarkers Market Under COVID-19
7.6 Spain Cancer Biomarkers Sales and Growth Rate (2015-2020)
7.6.1 Spain Cancer Biomarkers Market Under COVID-19
7.7 Russia Cancer Biomarkers Sales and Growth Rate (2015-2020)
7.7.1 Russia Cancer Biomarkers Market Under COVID-19

8 Asia-Pacific Cancer Biomarkers Market Analysis by Countries
8.1 Asia-Pacific Cancer Biomarkers Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Cancer Biomarkers Sales by Countries (2015-2020)
8.1.2 Asia-Pacific Cancer Biomarkers Revenue by Countries (2015-2020)
8.1.3 Asia-Pacific Cancer Biomarkers Market Under COVID-19
8.2 China Cancer Biomarkers Sales and Growth Rate (2015-2020)
8.2.1 China Cancer Biomarkers Market Under COVID-19
8.3 Japan Cancer Biomarkers Sales and Growth Rate (2015-2020)
8.3.1 Japan Cancer Biomarkers Market Under COVID-19
8.4 South Korea Cancer Biomarkers Sales and Growth Rate (2015-2020)
8.4.1 South Korea Cancer Biomarkers Market Under COVID-19
8.5 Australia Cancer Biomarkers Sales and Growth Rate (2015-2020)
8.6 India Cancer Biomarkers Sales and Growth Rate (2015-2020)
8.6.1 India Cancer Biomarkers Market Under COVID-19
8.7 Southeast Asia Cancer Biomarkers Sales and Growth Rate (2015-2020)
8.7.1 Southeast Asia Cancer Biomarkers Market Under COVID-19

9 Middle East and Africa Cancer Biomarkers Market Analysis by Countries
9.1 Middle East and Africa Cancer Biomarkers Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Cancer Biomarkers Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Cancer Biomarkers Revenue by Countries (2015-2020)
9.1.3 Middle East and Africa Cancer Biomarkers Market Under COVID-19
9.2 Saudi Arabia Cancer Biomarkers Sales and Growth Rate (2015-2020)
9.3 UAE Cancer Biomarkers Sales and Growth Rate (2015-2020)
9.4 Egypt Cancer Biomarkers Sales and Growth Rate (2015-2020)
9.5 Nigeria Cancer Biomarkers Sales and Growth Rate (2015-2020)
9.6 South Africa Cancer Biomarkers Sales and Growth Rate (2015-2020)

10 South America Cancer Biomarkers Market Analysis by Countries
10.1 South America Cancer Biomarkers Sales, Revenue and Market Share by Countries
10.1.1 South America Cancer Biomarkers Sales by Countries (2015-2020)
10.1.2 South America Cancer Biomarkers Revenue by Countries (2015-2020)
10.1.3 South America Cancer Biomarkers Market Under COVID-19
10.2 Brazil Cancer Biomarkers Sales and Growth Rate (2015-2020)
10.2.1 Brazil Cancer Biomarkers Market Under COVID-19
10.3 Argentina Cancer Biomarkers Sales and Growth Rate (2015-2020)
10.4 Columbia Cancer Biomarkers Sales and Growth Rate (2015-2020)
10.5 Chile Cancer Biomarkers Sales and Growth Rate (2015-2020)

11 Global Cancer Biomarkers Market Segment by Types
11.1 Global Cancer Biomarkers Sales, Revenue and Market Share by Types (2015-2020)
11.1.1 Global Cancer Biomarkers Sales and Market Share by Types (2015-2020)
11.1.2 Global Cancer Biomarkers Revenue and Market Share by Types (2015-2020)
11.2 Genetic Biomarkers Sales and Price (2015-2020)
11.3 Protein Biomarkers Sales and Price (2015-2020)
11.4 Glyco-biomarkers Sales and Price (2015-2020)

12 Global Cancer Biomarkers Market Segment by Applications
12.1 Global Cancer Biomarkers Sales, Revenue and Market Share by Applications (2015-2020)
12.1.1 Global Cancer Biomarkers Sales and Market Share by Applications (2015-2020)
12.1.2 Global Cancer Biomarkers Revenue and Market Share by Applications (2015-2020)
12.2 Diagnostics Sales, Revenue and Growth Rate (2015-2020)
12.3 Drug Discovery and Development Sales, Revenue and Growth Rate (2015-2020)
12.4 Prognostics Sales, Revenue and Growth Rate (2015-2020)
12.5 Risk Assessment Sales, Revenue and Growth Rate (2015-2020)
12.6 Others Sales, Revenue and Growth Rate (2015-2020)

13 Cancer Biomarkers Market Forecast by Regions (2020-2026)
13.1 Global Cancer Biomarkers Sales, Revenue and Growth Rate (2020-2026)
13.2 Cancer Biomarkers Market Forecast by Regions (2020-2026)
13.2.1 North America Cancer Biomarkers Market Forecast (2020-2026)
13.2.2 Europe Cancer Biomarkers Market Forecast (2020-2026)
13.2.3 Asia-Pacific Cancer Biomarkers Market Forecast (2020-2026)
13.2.4 Middle East and Africa Cancer Biomarkers Market Forecast (2020-2026)
13.2.5 South America Cancer Biomarkers Market Forecast (2020-2026)
13.3 Cancer Biomarkers Market Forecast by Types (2020-2026)
13.4 Cancer Biomarkers Market Forecast by Applications (2020-2026)
13.5 Cancer Biomarkers Market Forecast Under COVID-19

14 Appendix
14.1 Methodology
14.2 Research Data Source


                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)3400 View Pricing